Literature DB >> 3737654

Characterization of NGP 1-01, an aromatic polycyclic amine, as a calcium antagonist.

C J Van der Schyf, G J Squier, W A Coetzee.   

Abstract

Primary pharmacological and electrophysiological screening procedures were carried out on the aromatic polycyclic amine 3-hydroxy-4-benzyl-4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8, 11]- dodecane (NGP 1-01). Effects observed in the isolated guinea-pig atria and ileum were, respectively, reversal of CaCl2 induced positive chronotropy and inotropy and papaverine-like depression of the dose-response curve induced by acetyl choline. Electrophysiological studies using isolated guinea-pig papillary muscle showed a reduction in the action potential (AP) plateau potential and an increase in AP duration with accompanying negative inotropic effects. The calcium-mediated (slow response) AP was completely, but reversibly blocked by NGP 1-01 at concentrations of 5 X 10(-5) M and higher. Experiments on sheep Purkinje fibres strongly supported the finding that NGP 1-01 blocks the slow inward (calcium dependent) current Isi, but also suggested a decrease brought about in an outward current, most probably the background potassium current, IK1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3737654     DOI: 10.1016/0031-6989(86)90162-1

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  7 in total

Review 1.  Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?

Authors:  Cornelis J Van der Schyf; Werner J Geldenhuys
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

2.  Development and validation of an LC-MS/MS method for determination of the L-type voltage-gated calcium channel/NMDA receptor antagonist NGP1-01 in mouse serum.

Authors:  Harini Jogiraju; Xiang Zhou; Ashta Lakshmi Prasad Gobburi; Kiran K Pedada; Werner J Geldenhuys; Cornelis J Van der Schyf; Samuel D Crish; David J Anderson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-02       Impact factor: 3.205

3.  NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels.

Authors:  Cornelia Kiewert; Joachim Hartmann; James Stoll; Thomas J Thekkumkara; Cornelis J Van der Schyf; Jochen Klein
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

4.  Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.

Authors:  Lois-May Young; Werner J Geldenhuys; Olwen C Domingo; Sarel F Malan; Cornelis J Van der Schyf
Journal:  Arch Pharm (Weinheim)       Date:  2016-02-19       Impact factor: 3.751

Review 5.  Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives.

Authors:  Francesca Serena Abatematteo; Mauro Niso; Marialessandra Contino; Marcello Leopoldo; Carmen Abate
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

6.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

7.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

Authors:  Moussa B H Youdim
Journal:  Exp Neurobiol       Date:  2010-06-30       Impact factor: 3.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.